Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/30/2010US20100330061 Methods and Devices for Treating Lung Dysfunction
12/30/2010US20100330060 Glycopegylated factor ix
12/30/2010US20100330059 Chimeric factor vii molecules
12/30/2010US20100330058 Chewable drug
12/30/2010US20100330053 Mixed-cell gene therapy
12/30/2010US20100330050 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
12/30/2010US20100330042 Use of Proinsulin for the Preparation of a Neuroprotective Pharmaceutical Composition, Therapeutic Composition Containing it and Applications Thereof
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330035 Pharmaceutical Compositions for Treatment of HCV Patients that are Poor-Responders to Interferon
12/30/2010US20100330033 Protein-carrier conjugates
12/30/2010US20100330032 Heterocyclic antiviral compounds
12/30/2010US20100330031 Polypeptide having an improved cytosine deaminase activity
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100330029 Cancer Treatments with Radiation and Immunocytokines
12/30/2010US20100330028 Combination therapy for chronic dermal ulcers
12/30/2010US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
12/30/2010US20100330013 Amadoriases in washing and cleaning products
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
12/30/2010US20100329988 Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide
12/30/2010US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases
12/30/2010US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery
12/30/2010US20100329982 Particles with inducible change of shape
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/30/2010CA2706212A1 Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
12/29/2010WO2010151831A1 Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout
12/29/2010WO2010151823A1 Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
12/29/2010WO2010151755A2 TREATMENT OF INFLAMMATORY DISEASES USING miR-124
12/29/2010WO2010151736A1 Chimeric factor vii molecules
12/29/2010WO2010151707A1 Stabilizing alkylglycoside compositions and methods thereof
12/29/2010WO2010151699A1 Methods for diagnosing irritable bowel syndrome
12/29/2010WO2010151675A1 Active cores of peptide triazole hiv-1 entry inhibitors
12/29/2010WO2010151638A1 Jnk inhibitors for use in treating spinal muscular atrophy
12/29/2010WO2010151495A2 Materials and methods for treating and preventing viral infections
12/29/2010WO2010151426A1 Truncated actriib-fc fusion proteins
12/29/2010WO2010151338A2 Myostatin inhibitor enhancement of musculoskeletal repair
12/29/2010WO2010150982A2 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
12/29/2010WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150282A1 Novel polynucleotide molecules for enhanced gene expression
12/29/2010WO2010150257A2 A method and device for improving glycemic control based on residual insulin
12/29/2010WO2010150082A2 Use of chromogranin a and of peptidic derivatives thereof in the treatment of inflammation
12/29/2010WO2010150079A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
12/29/2010WO2010149960A1 Avian colony stimulating factor 1 receptor binding proteins
12/29/2010WO2010149907A1 Factor vii composition
12/29/2010WO2010149792A2 Antimicrobial agents
12/29/2010WO2010149772A1 Preparation comprising insulin, nicotinamide and an amino acid
12/29/2010WO2010149657A1 Method for the purification of hbha
12/29/2010WO2010149596A1 Compositions for treating degenerative joint diseases
12/29/2010WO2010149459A1 Use of hat inhibitors and tmprss2 inhibitors as medicaments
12/29/2010WO2010149357A2 Methods of using corticotropin-releasing factor for the treatment of cancer
12/29/2010WO2010149281A1 Use of cd44v6 in the treatment of ophthalmic diseases
12/29/2010WO2010149172A2 SYSTEMIC PRO-HEMOSTATIC EFFECT OF CLOTTING FACTORS IN COMBINATION WITH SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH.
12/29/2010WO2010149016A1 New compound and use thereof
12/29/2010WO2010148422A1 Compounds and methods for treating parasitic infestations
12/29/2010WO2010121207A9 Methods and compositions related to the interaction of t-cadherin and adiponectin
12/29/2010WO2010106509A3 Hcv-derived polypeptides and uses thereof
12/29/2010WO2010101353A9 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer
12/29/2010WO2010072327A3 Pharmaceutical composition based on peptide from camel milk
12/29/2010WO2009156071A8 Combination of amidine derivates with cyclic depsipeptides
12/29/2010WO2009146463A8 Variant hhip1 protein and methods and uses thereof
12/29/2010EP2267457A1 Beta 2-microglobulin biomarker for diagnosing diabetic retinopathy
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267135A2 Protein glycosylation modification in pichia pastoris
12/29/2010EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination
12/29/2010EP2267131A1 Genetic inhibition by double-stranded RNA
12/29/2010EP2267130A2 Bitter taste receptors
12/29/2010EP2267129A2 Bitter taste receptors
12/29/2010EP2267128A2 Bitter taste receptors
12/29/2010EP2267117A2 Differentiation modulating agents and uses therefor
12/29/2010EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267025A2 Purification of fibrinogen
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267010A2 Activatable recombinant neurotoxins
12/29/2010EP2267009A2 Activatable recombinant neurotoxins
12/29/2010EP2267008A2 Activatable recombinant neurotoxins
12/29/2010EP2267004A2 Peptide derived from hepatitis C virus
12/29/2010EP2267002A2 Antimicrobial polypeptides
12/29/2010EP2267001A2 Antimicrobial polypeptides
12/29/2010EP2267000A2 Antimicrobial polypeptides
12/29/2010EP2266999A2 Compounds for proteasome enzym inhibition
12/29/2010EP2266995A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
12/29/2010EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2266607A2 Immunoconjugates for treating cancer
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 3163